Literature DB >> 24101855

Serum iron may not be linked with migraine.

Ravi Gupta1, Vivekananda Lahan, Deepak Goel.   

Abstract

Entities:  

Year:  2013        PMID: 24101855      PMCID: PMC3788319          DOI: 10.4103/0972-2327.116959

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.383


× No keyword cloud information.
Sir, ‘We are thankful to the authors for their interest in this manuscript.[1] We agree with the fact that exclusion of subjects with iron deficiency would have improved the quality of our study. To support it, they have cited a study that shows that iron deficiency might be related to menstrual migraine.[2] We did not consider exclusion of iron-deficient subjects owing to a number of facts: First, this was not the aim of the study; second, considering a high prevalence of iron deficiency in India, this was not practical; lastly, iron deficiency has been reported in a number of Restless Legs Syndrome patients. As far as the relationship between iron and migraine is considered, this could be an over-simplistic explanation for this complex issue. The cited article had enrolled subjects with migraine whereas inclusion criterion in the present study was RLS.[2] Hence, both the studies cannot be compared directly. In addition, that study had found a relationship between menstrual migraine and iron deficiency but not between migraine and iron deficiency.[2] Thus, this finding cannot be generalized to all migraineurs. Moreover, a study that enrolled the RLS patients, like our study, did not find any effect of serum iron on the migraine.[3] To make the issue more complex, a number of studies have reported increased iron depiction in deep brain nuclei among migraineurs.[45] On the other hand, iron has been found to be decreased in the central nervous system of RLS patients.[67] In conclusion, more work is required to understand this complex issue.
  7 in total

1.  Is iron deficiency anemia related to menstrual migraine? Post hoc analysis of an observational study evaluating clinical characteristics of patients with menstrual migraine.

Authors:  Vlasta Vuković-Cvetković; Davor Plavec; Arijana Lovrencić-Huzjan; Ivana Galinović; Vesna Serić; Vida Demarin
Journal:  Acta Clin Croat       Date:  2010-12       Impact factor: 0.780

2.  Evaluation of contributing factors to restless legs syndrome in migraine patients.

Authors:  Shiho Suzuki; Keisuke Suzuki; Masayuki Miyamoto; Tomoyuki Miyamoto; Yuka Watanabe; Ryotaro Takashima; Koichi Hirata
Journal:  J Neurol       Date:  2011-05-03       Impact factor: 4.849

3.  Severity of restless legs syndrome is inversely correlated with echogenicity of the substantia nigra in different neurodegenerative movement disorders. a preliminary observation.

Authors:  José Luiz Pedroso; Edson Bor-Seng-Shu; Andre C Felicio; Pedro Braga-Neto; Lívia A Dutra; Camila C de Aquino; Henrique B Ferraz; Gilmar F do Prado; Manoel J Teixeira; Orlando G Barsottini
Journal:  J Neurol Sci       Date:  2012-05-24       Impact factor: 3.181

4.  Profile of altered brain iron acquisition in restless legs syndrome.

Authors:  James R Connor; Padmavathi Ponnuru; Xin-Sheng Wang; Stephanie M Patton; Richard P Allen; Christopher J Earley
Journal:  Brain       Date:  2011-03-11       Impact factor: 13.501

Review 5.  Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study.

Authors:  M C Kruit; M A van Buchem; L J Launer; G M Terwindt; M D Ferrari
Journal:  Cephalalgia       Date:  2010-02       Impact factor: 6.292

6.  Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study.

Authors:  M C Kruit; L J Launer; J Overbosch; M A van Buchem; M D Ferrari
Journal:  Cephalalgia       Date:  2008-11-19       Impact factor: 6.292

7.  Primary headaches in restless legs syndrome patients.

Authors:  Ravi Gupta; Vivekananda Lahan; Deepak Goel
Journal:  Ann Indian Acad Neurol       Date:  2012-08       Impact factor: 1.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.